CCL2 and neoplasm: Other studies have reported that IL-8, GM-CSF, TNF-α, YAP1, CXCR2 and CCL2 promote G-MDSC recruitment in CRC and confer tumor immunotherapy resistance to CRC [308,311,318,319,320].